Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Bengaluru to Host Children’s Health Festival and Childhood Obesity Conference on November 15 Health
  • AAFT Becomes First Creative Institute to Reach 124 Batches, Sets New Benchmark Education
  • Leading Digital Marketing Company in Usa ARK Marketing Pro LLC: Leading the Way in Digital Marketing Innovation Business
  • IDV in Bike Insurance: Why Insured Declared Value Matters for Your Two-Wheeler Finance
  • FIRST GLIMPSE OF “JHAAD_PHOONK” GOES VIRAL – FILM TO RELEASE WINTER 2025 – World News Network Entertainment
  • Chandan Healthcare Awarded 10-Year PPP Contract in Assam; Combined PPP Contract Portfolio in Punjab and Assam Now Worth INR 550 Cr Business
  • Vedanta Aluminium Bags ‘Best Exporter Award’ from Govt of Odisha. Business
  • Mettle Tweed Ignites India’s Music Festival Season with Bold Techwear for the New Year Vibe Lifestyle

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Experts Call for Global Standardization of MGB/OAGB Surgery Health
  • Why LifeCell Diagnostics Is Emerging as India’s Most Trusted Preventive Health Partner Health
  • Are you looking for a non-surgical fix to your urinary issues? Health
  • World Health Day 2025: Expert Advice on Starting Healthy and Building a Bright Future Health
  • AVEE Kids Introduces an Exciting New Range of Natural Products for Children Aged 5 to 12 Health
  • From Heart Scares and Asthma Attacks to 27 Kg Weight Loss: Anurag Kashyap’s Healing Journey at Pema Wellness Health

Recent Posts

  • Capitol Hospital Urology Experts Advise: Don’t Ignore the Signs of Prostate Enlargement
  • Wooden Street Exclusively Launches the Veda Collection to Bring Timeless Indian Philosophy into Modern Living
  • Supreme Power Equipment Limited Secures Orders Worth Rs 113.61 Cr
  • Cupid Limited Announces Development of Nitrile Female Condom Targeting Global Monopoly Segment and Strategic Branding Alignment: “Made in India” with “Japanese Quality”
  • Chandan Healthcare Enters Maharashtra and West Bengal; Launches Mumbai, Kolkata & Kota Diagnostic Centres

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Ex-BharatPe CXO Ritesh Mohan Srivastava Joins Jindal Steel and Power as Chief AI Officer Business
  • Breaking Barriers, Building Global Careers: CPA with Miles Education
  • Meet Neel Shah, a 20-year-old Memelord millionaire and fastest-growing content creator on Instagram Lifestyle
  • “Experience ‘Hero Wali Feeling’”, says Bollywood star Ayushmann Khurrana in the new campaign for the premium innerwear brand- Ranjit Smart Business
  • Revolutionizing Business Banking and Identity Verification: PaySprint Launches, SprintVerify’s Candy, and PaySprint’s collaboration with InstaBill for SprintNXT Business
  • 12th National CSR summit “Role of CSR in Mission Viksit Bharat by 2047” held in New Delhi, Shri Nitin Gatkari Ji urges Community Engagement Business
  • Krishca Strapping Solutions Reports Strong H1 FY26: Total Income INR 92.77 Cr Up 45% YoY, EBITDA Jumps Nearly 58% Business
  • Online shopping platform ‘Jyo Shop’ dominates the global markets with its old school hand-embroidered products Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme